John Yates, MD

CMO
Radius Health Inc.
Clinical Science
Papers:
OR22-3 The PTHrP1-34 Analog, Abaloparatide (BA058), Induces Consistent, Marked and Rapid Increases in Hip and Spine BMD with Compared to Placebo and Teriparatide
OR22-4 A Transdermal Patch Delivering the PTHrP1-34 Analog, Abaloparatide (BA058), Dose-Dependently Increases Spine and Hip BMD Compared to Placebo